Aurobindo Pharma Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -

1,570.90 +10.35 (0.66%)Updated : 21 Jul 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	-692.66	1,493.88	1,314.71	2,365.14
Net Changein Cash	1,627.61	2,178.36	-1,006.84	229.76
Cash Taxes Paid	1,832.03	1,731.35	1,766.64	717.24
Net Income/ Starting Line	5,111.85	5,066.29	4,379.99	2,612.50
Total Cash Dividends Paid	-232.40	-1.04	-263.64	-439.53
Changesin Working Capital	-1,667.92	-2,975.17	-3,441.71	-1,805.81
Cashfrom Operating Activities	5,526.55	3,925.28	2,434.52	2,393.16
Cash Interest Paid	344.09	420.32	250.65	111.20
Cashfrom Financing Activities	-1,269.15	119.78	800.42	1,814.41
Issuance( Retirement)of Stock Net	0.00	-930.24	-	-
Depreciation/ Depletion	1,778.19	1,649.42	1,521.66	1,244.58
Other Investing Cash Flow Items Total	-353.94	643.75	-694.45	-1,257.35
Capital Expenditures	-3,104.67	-2,519.55	-3,561.50	-2,720.40
period Type	-	-	-	-
Foreign Exchange Effects	828.82	9.10	14.17	-0.06
Non- Cash Items	304.43	184.74	-25.42	341.89
Financing Cash Flow Items	-344.09	-442.82	-250.65	-111.20
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-3,458.61	-1,875.80	-4,255.95	-3,977.75

*All figures in crores except per share values

Trending Stocks

1,570.50+59.15(3.91%)

389.85+12.70(3.37%)

2,268.25+66.45(3.02%)

1,933.10-16.90 (-0.87%)

2,840.00-19.55 (-0.68%)

Related News